Posted on 8/1/18
Bellerophon Provides Business Update and Reports Second Quarter 2018 Financial Results
WARREN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results . . .
Posted on 8/1/18
Tabula Rasa HealthCare Expands Medication Risk Mitigation Offerings to Western Europe
MOORESTOWN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced it . . .
Posted on 8/1/18
Pernix Therapeutics Announces a Series of Transactions to Strengthen Its Balance Sheet and Improve Financial Flexibility
MORRISTOWN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announces a series of transactions aimed at strengthening its . . .
Posted on 8/1/18
Marks & Spencer Expands Partnership with First Insight
PITTSBURGH & LONDON--(BUSINESS WIRE)--First Insight, Inc., a global technology company transforming how leading retailers make product investment and pricing decisions, and Marks and Spencer (M&S), (LON: . . .
Posted on 8/1/18
Pfizer, Inc. (PFE) Q2 2018 Earnings Conference Call Transcript
IMAGE SOURCE: THE MOTLEY FOOL.Pfizer, Inc. (NYSE:PFE)Q2 2018 Earnings Conference CallJuly 31, 2018, 10:00 a.m. ETContents:Prepared RemarksQuestions and AnswersCall ParticipantsPrepared Remarks:OperatorGood day everyone and welcome to . . .
Posted on 8/1/18
7 Things You Might Have Missed With Pfizer's Q2 Earnings Results
Pfizer (NYSE:PFE) announced its second-quarter earnings results before the market opened on Tuesday. How good were those results? Pretty good on some counts, but mediocre on . . .
Posted on 7/31/18
TransCelerate and BioCelerate Launch New Technology Platform
PHILADELPHIA--(BUSINESS WIRE)--TransCelerate BioPharma Inc., and BioCelerate announce that its new technology platform, DataCelerateTM, is live and accessible to participating TransCelerate and BioCelerate Member Companies. The global . . .
Posted on 7/31/18
Ortho Clinical Diagnostics Achieves Distinguished No. 1 Ranking for Service Performance for 3rd Year in a Row
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that, for the third year in a row, the Ortho Care service and . . .
Posted on 7/31/18
AMETEK Acquires Motec GmbH
AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Motec GmbH, a leading provider of integrated vision systems serving the high growth . . .
Posted on 7/31/18
Antares Pharma to Report Second Quarter 2018 Financial and Operating Results
EWING, N.J., July 31, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2018 financial results and recent . . .
Posted on 7/31/18
On the Back of a Solid Quarter, Celgene Looks Ahead
Celgene (NASDAQ:CELG) posted solid second-quarter results thanks to ever-expanding sales of blood cancer drug Revlimid, but investors should be equally focused on the biotech's potential as . . .
Posted on 7/31/18
FOX Rehabilitation Joins enTouch Network in Pennsylvania and New Jersey
PreparedHealth today announced that FOX Rehabilitation has joined the enTouch Network to streamline health-related communication around their patients. FOX Rehabilitation is a clinician-owned and operated professional . . .
Posted on 7/31/18
Immunomedics Announces Multiple Clinical and Preclinical Collaborations With Prominent Cancer Research Institutions
MORRIS PLAINS, N.J., July 30, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced . . .
Posted on 7/31/18
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
RADNOR, Pa., July 30, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and . . .
Posted on 7/30/18
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope
Daiichi Sankyo Company, Limited and Glycotope GmbH have entered into an exclusive worldwide licensing agreement to develop an antibody drug conjugate (ADC) by combining Daiichi Sankyo's proprietary ADC . . .
Posted on 7/30/18
Johnson & Johnson Consumer To Acquire Zarbee's
Johnson & Johnson Consumer Inc. announced today that it has entered into a definitive agreement to acquire Zarbee's, Inc., a privately held company that is a . . .
Posted on 7/30/18
Merck & Co Inc. (MRK) CEO Ken Frazier on Q2 2018 Results - Earnings Call Transcript
Merck & Co Inc. (NYSE:MRK) Q2 2018 Earnings Conference Call July 27, 2018 8:00 AM ETExecutivesTeri Loxam - IR & Global CommunicationsKen Frazier - Chairman and . . .
Posted on 7/30/18
Why Pfizer's Q2 Earnings Results Might Be Weaker Than You'd Like
When Pfizer (NYSE:PFE) reported its first-quarter results in May, there were things to like -- but things to dislike, too. The big pharma company's earnings soared . . .
Posted on 7/30/18
Why Celgene Is Looking Less Risky and More Attractive
Yes, Celgene (NASDAQ:CELG) is probably the riskiest big biotech on the planet. The company depends on one drug -- Revlimid -- for 64% of its revenue. . . .
Posted on 7/30/18
Can Celgene’s Most Important Drugs Keep Growing?
Celgene Corp. (NASDAQ:CELG) markets four billion-dollar blockbuster medicines, but only two were behind its stellar sales and profit performance in the second quarter. Sales of Revlimid . . .
Posted on 7/29/18
Aquestive Therapeutics Closes IPO
Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced the closing of its . . .
Posted on 7/29/18
Logic Biosciences Announces International Award for LBS-101 Program
NEWARK, N.J.--(BUSINESS WIRE)--Logic Biosciences, Inc., a development-stage pharmaceutical company, today announced that its lead product candidate, LBS-101, has been recognized with an Innovation in Oral Care . . .
Posted on 7/27/18
Idera Pharmaceuticals Announces One-for-Eight Reverse Stock Split
EXTON, Pa., July 27, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune . . .
Posted on 7/27/18
Merck Announces Second-Quarter 2018 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2018.“Strong commercial execution . . .
Posted on 7/27/18
Nabriva Therapeutics Prices Public Offering of Ordinary Shares of Approximately $50M
DUBLIN, Ireland and KING OF PRUSSIA, Pa., July 26, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced the pricing of its underwritten public offering . . .

